AZD1163 Clinical Trials (2026): 2 Studies for Healthy Volunteers & Rheumatoid Arthritis
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 AZD1163 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Healthy Volunteers & Rheumatoid Arthritis) and 428 total planned enrollment. 1 AZD1163 clinical trial is actively recruiting at 8 U.S. sites across 5 states. Most recent activity: NCT07276581 (Aug 2028).
Where to Participate: All AZD1163 Trial Sites in the U.S. (8 sites across 5 states)
Every actively recruiting AZD1163trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| FL | Research Site | South Miami33143 | NCT07276581 | Map |
| IL | Research Site | Willowbrook60527 | NCT07276581 | Map |
| MA | Research Site | New Bedford02740 | NCT07276581 | Map |
| NV | Research Site | Henderson89052 | NCT07276581 | Map |
| TX | Research Site | Austin78745 | NCT07276581 | Map |
| TX | Research Site | Baytown77521 | NCT07276581 | Map |
| TX | Research Site | Houston77089 | NCT07276581 | Map |
| TX | Research Site | Tomball77375 | NCT07276581 | Map |
AZD1163 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | completed | Total |
|---|---|---|---|
| P1 | 1 | 1 | |
| P2 | 1 | 1 |
Recruiting AZD1163 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07276581 | LaunchPAD-RAA Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis | P2 | Rheumatoid Arthritis | 320 | Dec 2025 |
AZD1163 clinical trials by indication
Rheumatoid Arthritis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07276581 | LaunchPAD-RA | P2 | recruiting | A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis |
Healthy Volunteers (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06103877 | IV | P1 | completed | A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy Volunteers |
AZD1163 pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| LaunchPAD-RA | NCT07276581 | P2 | recruiting | Rheumatoid Arthritis | 320 | — |
All AZD1163 trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07276581 | LaunchPAD-RA | A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis | P2 | recruiting | 320 | AstraZeneca | Dec 2025 |
| NCT06103877 | IV | A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy Volunteers | P1 | completed | 108 | AstraZeneca | Nov 2023 |
AZD1163 clinical trials: frequently asked questions
- How many AZD1163 clinical trials are there?
- 2 AZD1163 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 1 is marked completed.
- Are AZD1163 clinical trials recruiting in 2026?
- Yes — 1 AZD1163 trial is actively recruiting in 2026, with 8 U.S. sites across 5 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is AZD1163 being studied for?
- AZD1163 is being studied for Healthy Volunteers, Rheumatoid Arthritis. The trials are grouped by indication on this page.
- What phase is AZD1163 in?
- AZD1163 clinical trials span 1 Phase 2, 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors AZD1163 clinical trials?
- The lead sponsor across the most AZD1163 trials is AstraZeneca. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming AZD1163as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: